Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 9Phase 4 6Phase 2/3 4Phase 1/2 3Phase 1 2Phase NA 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Carcinoma, Hepatocellular 1

Interventions

Exercise 57Radiotherapy 49Blood Specimen Collection 45Radiosurgery 35Drug Therapy 33Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19Control Groups 19camrelizumab 16Propofol 16Metformin 16Cytarabine 16Surveys and Questionnaires 15Preoperative Exercise 15Injections 15Fluorouracil 15anlotinib 14Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Unknown × Thalidomide × Clear all
NCT01924624 2013-08-16

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

The First Affiliated Hospital of Xiamen University

Phase NA Unknown
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡